138 related articles for article (PubMed ID: 35401794)
1. Radiation-induced enterocolitis after combination therapy with palliative radiotherapy and immune checkpoint inhibitors in patients with metastatic lung cancer.
Makita K; Hamamoto Y; Kanzaki H; Nagasaki K; Sugawara Y; Ninomiya T; Harada D; Kozuki T
Exp Ther Med; 2022 May; 23(5):336. PubMed ID: 35401794
[TBL] [Abstract][Full Text] [Related]
2. Palliative Radiation Therapy for Vertebral Metastases and Metastatic Cord Compression in Patients Treated With Anti-PD-1 Therapy.
Fareed MM; Pike LRG; Bang A; Huynh MA; Taylor A; Spektor A; Awad MM; Ott PA; Krishnan M; Balboni TA; Schoenfeld JD
Front Oncol; 2019; 9():199. PubMed ID: 30984622
[No Abstract] [Full Text] [Related]
3. Dosimetric Risk Factors for Acute Radiation Pneumonitis in Patients With Prior Receipt of Immune Checkpoint Inhibitors.
Bi J; Qian J; Yang D; Sun L; Lin S; Li Y; Xue X; Nie T; Verma V; Han G
Front Immunol; 2021; 12():828858. PubMed ID: 35095930
[TBL] [Abstract][Full Text] [Related]
4. Palliative radiotherapy for tumor bleeding in patients with unresectable pancreatic cancer: a single-center retrospective study.
Shibuki T; Sasaki M; Yamaguchi S; Inoue K; Taira T; Satake T; Watanabe K; Imaoka H; Mitsunaga S; Fujisawa T; Tomizawa K; Oyoshi H; Nakamura M; Hojo H; Ikeda M
Radiat Oncol; 2023 Oct; 18(1):178. PubMed ID: 37907912
[TBL] [Abstract][Full Text] [Related]
5. Incidence and risk factors for pneumonitis among patients with lung cancer who received immune checkpoint inhibitors after palliative thoracic radiotherapy.
Saito S; Abe T; Iino M; Aoshika T; Ryuno Y; Ohta T; Igari M; Hirai R; Kumazaki Y; Yamaguchi O; Kaira K; Kagamu H; Noda SE; Kato S
J Radiat Res; 2021 Jul; 62(4):669-675. PubMed ID: 34121123
[TBL] [Abstract][Full Text] [Related]
6. Brain injury after cranial radiotherapy combined with immunotherapy for brain metastases in lung cancer: a retrospective study.
Li J; Li W; Xu S; Zhu H
Future Oncol; 2023 Apr; 19(13):947-959. PubMed ID: 37199346
[No Abstract] [Full Text] [Related]
7. Analysis of patterns of palliative radiotherapy in north west India: a regional cancer center experience.
Kapoor A; Singhal MK; Kumar N; Kalwar A; Bagri PK; Narayan S; Nirban RK; Kumar HS
Indian J Palliat Care; 2015; 21(2):168-73. PubMed ID: 26009670
[TBL] [Abstract][Full Text] [Related]
8. Impact of high dose radiotherapy for breast tumor in locoregionally uncontrolled stage IV breast cancer: a need for a risk-stratified approach.
Kim N; Kim H; Park W; Cho WK; Kim TG; Im YH; Ahn JS; Park YH; Kim JY
Radiat Oncol; 2023 Oct; 18(1):168. PubMed ID: 37821947
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric factors predicting severe radiation-induced bowel complications in patients with cervical cancer: combined effect of external parametrial dose and cumulative rectal dose.
Huang EY; Wang CJ; Hsu HC; Hao Lin ; Chen HC; Sun LM
Gynecol Oncol; 2004 Oct; 95(1):101-8. PubMed ID: 15385117
[TBL] [Abstract][Full Text] [Related]
10. Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers.
Onimaru R; Shirato H; Shimizu S; Kitamura K; Xu B; Fukumoto S; Chang TC; Fujita K; Oita M; Miyasaka K; Nishimura M; Dosaka-Akita H
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):126-35. PubMed ID: 12694831
[TBL] [Abstract][Full Text] [Related]
11. Palliative Radiation Therapy in Bladder Cancer-Importance of Patient Selection: A Retrospective Multicenter Study.
Ali A; Song YP; Mehta S; Mistry H; Conroy R; Coyle C; Logue J; Tran A; Wylie J; Janjua T; Joseph L; Joseph J; Choudhury A
Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):389-393. PubMed ID: 31283979
[TBL] [Abstract][Full Text] [Related]
12. Palliative radiotherapy in advanced cancer patients treated with immune-checkpoint inhibitors: The PRACTICE study.
Bersanelli M; Lattanzi E; D'Abbiero N; Buti S; Leonetti A; Canè MG; Trapani S; Gravina G; Porzio G; Cannita K; Marino PD; Grassadonia A; Tinari N; Tursi M; Giaiacopi E; Michiara M; Bordi P; Perrone F; Caravatta L; Trignani M; Genovesi D; Natoli C; Ficorella C; Tiseo M; Cortellini A
Biomed Rep; 2020 Feb; 12(2):59-67. PubMed ID: 31929875
[TBL] [Abstract][Full Text] [Related]
13. Time factor in postoperative radiotherapy: a multivariate locoregional control analysis in 868 patients.
Suwinski R; Sowa A; Rutkowski T; Wydmanski J; Tarnawski R; Maciejewski B
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):399-412. PubMed ID: 12738315
[TBL] [Abstract][Full Text] [Related]
14. Palliative Appropriateness Criteria: A Pragmatic Method to Evaluate the Suitability of Palliative Radiotherapy Fractionation.
Farris JC; Johnson AG; Carriere PP; Patel ZA; Nagatsuka M; Farris MK; Hughes RT
J Palliat Med; 2023 Jan; 26(1):67-72. PubMed ID: 35881861
[No Abstract] [Full Text] [Related]
15. Palliative Quad Shot Radiation Therapy with or without Concurrent Immune Checkpoint Inhibition for Head and Neck Cancer.
Upadhyay R; Gogineni E; Tocaj G; Ma SJ; Bonomi M; Bhateja P; Konieczkowski DJ; Baliga S; Mitchell DL; Jhawar SR; Zhu S; Grecula JC; Dibs K; Gamez ME; Blakaj DM
Cancers (Basel); 2024 Mar; 16(5):. PubMed ID: 38473406
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric study of pelvic proton radiotherapy for high-risk prostate cancer.
Chera BS; Vargas C; Morris CG; Louis D; Flampouri S; Yeung D; Duvvuri S; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):994-1002. PubMed ID: 19619961
[TBL] [Abstract][Full Text] [Related]
18. Safety of thoracic radiotherapy in patients with prior immune-related adverse events from immune checkpoint inhibitors.
Shaverdian N; Beattie J; Thor M; Offin M; Shepherd AF; Gelblum DY; Wu AJ; Simone CB; Hellmann MD; Chaft JE; Rimner A; Gomez DR
Ann Oncol; 2020 Dec; 31(12):1719-1724. PubMed ID: 33010460
[TBL] [Abstract][Full Text] [Related]
19. An Analysis of Clinical and Systemic Factors Associated with Palliative Radiotherapy Delivery and Completion at the End of Life in Alberta, Canada.
Goutam S; Ghosh S; Stosky J; Tam A; Quirk S; Fairchild A; Wu J; Kerba M
Curr Oncol; 2023 Nov; 30(12):10043-10056. PubMed ID: 38132364
[TBL] [Abstract][Full Text] [Related]
20. Pulsed Radiation Therapy With Concurrent Cisplatin Results in Superior Tumor Growth Delay in a Head and Neck Squamous Cell Carcinoma Murine Model.
Meyer K; Krueger SA; Kane JL; Wilson TG; Hanna A; Dabjan M; Hege KM; Wilson GD; Grills I; Marples B
Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):161-9. PubMed ID: 27511853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
